Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Somethings is a platform for wellness tailored to young people that links youngsters with qualified mentors.
Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.
Ensomaa is a genomic medicine company that develops on one-time in vivo treatments for immuno-oncology and other therapeutic applications.
Character Bio is a platform that merges genomics with clinical data and AI technology, focusing on patients affected by AMD.
OSPRI is updating the infectious illness testing plan.
Amalgam Rx develops and distributes digital health products that support patients and healthcare providers in decision-making.
SetPoint Medical provides a device-based therapy for rheumatoid arthritis.
Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.
GlycoEra is a biotechnology research company that produces extracellular protein degraders for the treatment of autoimmune diseases.
Syndeio Biosciences is a newly launched biotech company pioneering precision neurotherapeutics.
Imbria Pharmaceuticals is a clinical stage biotechnology company developing novel therapies for cardiometabolic diseases.
Elektrofi is a preclinical-stage company dedicated to redefining the standard of drug delivery by transforming the patient experience.
Roshal Imaging Services is a provider of on-site and portable diagnostic Vascular and General body (OB/Gyn) ultrasound services.
OnCusp Therapeutics is a biopharmaceutical company turning cutting-edge research assets into innovative oncology treatments.
Lassen Therapeutics develops antibody biotherapeutics to help improve the lives of patients suffering from serious diseases.
Aviceda Therapeutics is a late-stage pre-clinical biotech company developing drugs for treating glyco-immune diseases.
Perceive Biotherapeutics is a biotechnology company pioneering novel technologies and therapeutics in ophthalmology.
Metagenomi uses metagenomics and machine learning to discover novel genome editing systems for therapeutics development.
Medical Informatics offers solutions that give care teams access to the data they need to take action for alarm management and safety.
Sidera Bio harness human genetics, that helps in transformative medicines for patients.
Protara Therapeutics develops transformative therapies for people with cancer and rare diseases with limited treatment options.
PinkDx is a biotechnology company.
Glympse Bio is a biotechnology company that transforms disease detection and predict treatment response.
Medra AI develops an autonomous scientific experimentation platform that combines robotics with artificial intelligence.
Catalio Capital Management has invested in 137 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Catalio Capital Management's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Life Science. The firm invests across 27 different industry categories.
Among tracked funding rounds, Aviceda Therapeutics received $207.5M in a Series C round. Catalio Capital Management's total known invested capital is $10.0B.
Catalio Capital Management's average investment size is $76.1M across its portfolio of 137 companies.
Recent Catalio Capital Management portfolio additions include Somethings, Star Therapeutics, Ensoma, Character Biosciences, OSPRI. These companies were founded in 2020 or later.